Federal Supply Schedule 36F79724D0130
Award Date
7/1/24
Last Date to Order
6/30/29
Federal Agency
Veterans Integrated Service Network 12
Awardee
Pfizer Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
Pfizer Inc. holds a Federal Supply Schedule (FSS-61-IB) contract with the U.S. General Services Administration to provide pharmaceuticals and drugs to federal agencies. This $6.25 billion multiple-award contract enables Pfizer to deliver a wide range of pharmaceutical products, including controlled substances, antibiotics, vaccines, and other medications, to support the healthcare needs of federal customers such as the Department of Defense, Department of Veterans Affairs, and Centers for...
The provided information describes an Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc., a leading global pharmaceutical corporation. The $425.5 million IDC, with a period of performance running from June 2023 to June 2024, is for the procurement of adult COVID-19 vaccines.
As a major supplier of pharmaceutical products and vaccines to the U.S. federal government, Pfizer holds several significant Indefinite Delivery Vehicles...
This Indefinite Delivery Contract (IDC) with a ceiling value of $347,200,000.00 was awarded to Pfizer Inc. on June 1, 2024 by the Centers for Disease Control and Prevention (CDC) to provide COVID-19 adult vaccines. The contract has a period of performance through September 30, 2025 and was awarded without any set-aside designation, reflecting Pfizer's status as a large pharmaceutical corporation.
Under this IDC, Pfizer will supply a variety of adult vaccines to support the CDC's public health...
The Department of Veterans Affairs awarded a Federal Supply Schedule (FSS) contract to Hospira Worldwide LLC, a subsidiary of Pfizer Inc., for a wide range of pharmaceutical and medical products under the FSS-61 IB schedule. The $230 million multiple-award contract has a period of performance running from October 1, 2014 through June 30, 2024.
Through this FSS contract, Hospira/Pfizer has provided sterile injectable drugs, antibiotics, anesthetics, IV solutions, and other medical supplies to...
Pfizer Inc. is providing adult vaccines to the Centers for Disease Control and Prevention under a multiple award indefinite delivery contract. The contract was awarded on July 1, 2020 with a potential value of $48.8 million. Pfizer will supply vaccines for hepatitis A & B, pneumococcal disease, tetanus, diphtheria, herpes zoster, pertussis, measles, mumps, rubella, meningitis, human papillomavirus, varicella, and serogroup B meningococcal disease. Delivery will support immunization...
The federal contract IDV award, with ID SPE2D020D0014, is a single-award Indefinite Delivery Contract issued by the Defense Logistics Agency Troop Support Medical, a component of the Department of Defense. The prime contractor is Pfizer Inc., a global pharmaceutical corporation.
The contract, valued at up to $48,683,160.88, is for the manufacture and distribution of a wide range of pharmaceutical products, including controlled substances such as fentanyl and morphine, antibiotics like...
This indefinite delivery contract was awarded by the Centers for Disease Control and Prevention (CDC) to Pfizer Inc. to supply a variety of standard pediatric vaccines over a 12-month period. The contract, valued at up to $1,530,970,000, will support the CDC's Vaccines for Children program, which provides immunizations to eligible children.
The contract covers 20 different pediatric vaccines, including DTaP, Hepatitis A and B, Hib, HPV, MMR, Pneumococcal, Rotavirus, and Varicella, with...
The Centers for Disease Control and Prevention (CDC) has awarded Pfizer Inc. an Indefinite Delivery Contract (IDC) for the supply of various adult vaccines to support immunization programs under Section 317(j) of the Public Health Service Act. The $103,060,230.33 contract, which runs from July 1, 2023 to June 30, 2024, covers a range of vaccines including hepatitis A, hepatitis B, pneumococcal polysaccharide, tetanus and diphtheria toxoids, herpes zoster, measles-mumps-rubella, meningococcal...
This Indefinite Delivery Contract (IDC) was awarded by the National Acquisition Center, a civilian agency of the U.S. federal government, to Pfizer Inc. as the prime contractor. The contract has a total ceiling value of $83,732,812.80 and a period of performance from September 15, 2020 to September 14, 2025, including a base year and four one-year option periods.
The purpose of this IDC is to procure rituximab vials for the Department of Veterans Affairs, Department of Defense, Bureau of...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), National Center for Immunization and Respiratory Diseases (NCIRD) to Pfizer Inc. to purchase a variety of pediatric vaccines for the Vaccines for Children (VFC) program. The $1.5 billion contract has a period of performance from April 1, 2023 to March 31, 2024.
The contract will procure a minimum of 100 doses up to maximum quantities ranging from 100,000 to 13 million doses for 21...